Diffusion Kurtosis Imaging as a Prognostic Marker in Osteosarcoma Patients with Preoperative Chemotherapy

Background. The accurate prediction of prognosis is key to prompt therapy adjustment. The purpose of our study was to investigate the efficacy of diffusion kurtosis imaging (DKI) in predicting progression-free survival (PFS) and overall survival (OS) in osteosarcoma patients with preoperative chemot...

Full description

Bibliographic Details
Main Authors: Chenglei Liu, Yue Xing, Dongmin Wei, Qiong Jiao, Qingcheng Yang, Dapeng Lei, Xiaofeng Tao, Weiwu Yao
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2020/3268138
id doaj-6cc5cb671fab4033b9f348612e94f187
record_format Article
spelling doaj-6cc5cb671fab4033b9f348612e94f1872020-11-25T03:27:44ZengHindawi LimitedBioMed Research International2314-61332314-61412020-01-01202010.1155/2020/32681383268138Diffusion Kurtosis Imaging as a Prognostic Marker in Osteosarcoma Patients with Preoperative ChemotherapyChenglei Liu0Yue Xing1Dongmin Wei2Qiong Jiao3Qingcheng Yang4Dapeng Lei5Xiaofeng Tao6Weiwu Yao7Department of Radiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Radiology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, ChinaDepartment of Otorhinolaryngology, Qilu Hospital, Shandong University, Shandong 250012, ChinaDepartment of Pathology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, ChinaDepartment of Orthopaedics, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, ChinaDepartment of Otorhinolaryngology, Qilu Hospital, Shandong University, Shandong 250012, ChinaDepartment of Radiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Radiology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, ChinaBackground. The accurate prediction of prognosis is key to prompt therapy adjustment. The purpose of our study was to investigate the efficacy of diffusion kurtosis imaging (DKI) in predicting progression-free survival (PFS) and overall survival (OS) in osteosarcoma patients with preoperative chemotherapy. Methods. Thirty patients who underwent DKI before and after chemotherapy, followed by tumor resection, were retrospectively enrolled. The patients were grouped into good responders (GRs) and poor responders (PRs). The Kaplan-Meier and log-rank test were used for survival analysis. The association between the DKI parameters and OS and PFS was performed by univariate and multivariate Cox proportional hazards models. Results. Significantly worse OS and PFS were associated with a lower mean diffusivity (MD) after chemotherapy (HR, 5.8; 95% CI, 1.5-23.1; P=0.012 and HR, 3.5; 95% CI, 1.2-10.1: P=0.028, respectively) and a higher mean kurtosis (MK) after chemotherapy (HR, 0.3; 95% CI, 0.1-0.9; P=0.041 and HR, 0.3; 95% CI, 0.1-0.8; P=0.049, respectively). Likewise, shorter OS and PFS were also significantly associated with a change rate in MD (CR MD) of less than 13.53% (HR, 8.6; 95% CI, 1.8-41.8; P=0.007 and HR, 2.9; 95% CI, 1.0-8.2; P=0.045, respectively). Compared to GRs, PRs had an approximately 9- and 4-fold increased risk of death (HR, 9.4; 95% CI, 1.2-75; P=0.034) and progression (HR, 4.2; 95% CI, 1.2-15; P=0.026), respectively. Conclusions. DKI has a potential to be a prognostic tool in osteosarcoma. Low MK and high MD after chemotherapy or high CR MD indicates favorite outcome, while prospective studies with large sample sizes are warranted.http://dx.doi.org/10.1155/2020/3268138
collection DOAJ
language English
format Article
sources DOAJ
author Chenglei Liu
Yue Xing
Dongmin Wei
Qiong Jiao
Qingcheng Yang
Dapeng Lei
Xiaofeng Tao
Weiwu Yao
spellingShingle Chenglei Liu
Yue Xing
Dongmin Wei
Qiong Jiao
Qingcheng Yang
Dapeng Lei
Xiaofeng Tao
Weiwu Yao
Diffusion Kurtosis Imaging as a Prognostic Marker in Osteosarcoma Patients with Preoperative Chemotherapy
BioMed Research International
author_facet Chenglei Liu
Yue Xing
Dongmin Wei
Qiong Jiao
Qingcheng Yang
Dapeng Lei
Xiaofeng Tao
Weiwu Yao
author_sort Chenglei Liu
title Diffusion Kurtosis Imaging as a Prognostic Marker in Osteosarcoma Patients with Preoperative Chemotherapy
title_short Diffusion Kurtosis Imaging as a Prognostic Marker in Osteosarcoma Patients with Preoperative Chemotherapy
title_full Diffusion Kurtosis Imaging as a Prognostic Marker in Osteosarcoma Patients with Preoperative Chemotherapy
title_fullStr Diffusion Kurtosis Imaging as a Prognostic Marker in Osteosarcoma Patients with Preoperative Chemotherapy
title_full_unstemmed Diffusion Kurtosis Imaging as a Prognostic Marker in Osteosarcoma Patients with Preoperative Chemotherapy
title_sort diffusion kurtosis imaging as a prognostic marker in osteosarcoma patients with preoperative chemotherapy
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2020-01-01
description Background. The accurate prediction of prognosis is key to prompt therapy adjustment. The purpose of our study was to investigate the efficacy of diffusion kurtosis imaging (DKI) in predicting progression-free survival (PFS) and overall survival (OS) in osteosarcoma patients with preoperative chemotherapy. Methods. Thirty patients who underwent DKI before and after chemotherapy, followed by tumor resection, were retrospectively enrolled. The patients were grouped into good responders (GRs) and poor responders (PRs). The Kaplan-Meier and log-rank test were used for survival analysis. The association between the DKI parameters and OS and PFS was performed by univariate and multivariate Cox proportional hazards models. Results. Significantly worse OS and PFS were associated with a lower mean diffusivity (MD) after chemotherapy (HR, 5.8; 95% CI, 1.5-23.1; P=0.012 and HR, 3.5; 95% CI, 1.2-10.1: P=0.028, respectively) and a higher mean kurtosis (MK) after chemotherapy (HR, 0.3; 95% CI, 0.1-0.9; P=0.041 and HR, 0.3; 95% CI, 0.1-0.8; P=0.049, respectively). Likewise, shorter OS and PFS were also significantly associated with a change rate in MD (CR MD) of less than 13.53% (HR, 8.6; 95% CI, 1.8-41.8; P=0.007 and HR, 2.9; 95% CI, 1.0-8.2; P=0.045, respectively). Compared to GRs, PRs had an approximately 9- and 4-fold increased risk of death (HR, 9.4; 95% CI, 1.2-75; P=0.034) and progression (HR, 4.2; 95% CI, 1.2-15; P=0.026), respectively. Conclusions. DKI has a potential to be a prognostic tool in osteosarcoma. Low MK and high MD after chemotherapy or high CR MD indicates favorite outcome, while prospective studies with large sample sizes are warranted.
url http://dx.doi.org/10.1155/2020/3268138
work_keys_str_mv AT chengleiliu diffusionkurtosisimagingasaprognosticmarkerinosteosarcomapatientswithpreoperativechemotherapy
AT yuexing diffusionkurtosisimagingasaprognosticmarkerinosteosarcomapatientswithpreoperativechemotherapy
AT dongminwei diffusionkurtosisimagingasaprognosticmarkerinosteosarcomapatientswithpreoperativechemotherapy
AT qiongjiao diffusionkurtosisimagingasaprognosticmarkerinosteosarcomapatientswithpreoperativechemotherapy
AT qingchengyang diffusionkurtosisimagingasaprognosticmarkerinosteosarcomapatientswithpreoperativechemotherapy
AT dapenglei diffusionkurtosisimagingasaprognosticmarkerinosteosarcomapatientswithpreoperativechemotherapy
AT xiaofengtao diffusionkurtosisimagingasaprognosticmarkerinosteosarcomapatientswithpreoperativechemotherapy
AT weiwuyao diffusionkurtosisimagingasaprognosticmarkerinosteosarcomapatientswithpreoperativechemotherapy
_version_ 1715208873307013120